创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels: The Advantages of Homologous Modeling

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-02-23 15:08
  • Views:

(Summary description)In the field of medical research, InnoModels Biotechnology has made great breakthroughs with its homology modeling technology. This technology provides scientists with a new way to better understand the mechanisms of disease, accelerate the drug discovery process, and enable personalized medicine

InnoModels: The Advantages of Homologous Modeling

(Summary description)In the field of medical research, InnoModels Biotechnology has made great breakthroughs with its homology modeling technology. This technology provides scientists with a new way to better understand the mechanisms of disease, accelerate the drug discovery process, and enable personalized medicine

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-02-23 15:08
  • Views:
Information

In the field of medical research, InnoModels Biotechnology has made great breakthroughs with its homology modeling technology. This technology provides scientists with a new way to better understand the mechanisms of disease, accelerate the drug discovery process, and enable personalized medicine. The following are the advantages of InnoModels' bio-homologous models:
1. Mimic human physiology
Homologous modeling technology allows scientists to use human cells to construct models that mimic the physiological characteristics of the human body. Compared with animal models, these homologous models can more accurately reflect the internal biological processes of the human body, which is more helpful in predicting the effects of drugs on the human body as well as the mechanisms of disease development.
2. Improving the accuracy of disease research
Homologous modeling technology allows researchers to build models of specific diseases, such as cancer and genetic diseases. These models can not only more accurately simulate the physiological and pathological processes of diseases, but can also be used to assess the effectiveness of potential treatments, providing important support for the development of precision medicine.
3. Realization of personalized medicine
Homologous model technology provides a new way to realize personalized medicine. By using patients' cells, scientists can construct models that match patients' biological characteristics, thus providing patients with personalized treatment plans and predicting the efficacy and side effects of specific treatments.

 


4. Accelerating the drug discovery process
The use of homology models for drug screening and toxicity testing can greatly accelerate the drug development process. Compared to traditional animal testing, homology models are more predictive and reliable, providing more accurate assessments of efficacy and toxicity and reducing the time and cost of drug development.
5. Enhancing the feasibility of alternative methods
With increasing concerns about the ethics and cost of animal testing, homologous modeling techniques offer a viable option for finding alternative methods. This technique not only reduces the reliance on animal experiments, but also improves the reproducibility and reliability of experimental results, thus promoting the development and application of alternative methods.
Conclusion
Homologous modeling technology of InnoModels provides scientists with a more accurate and reliable research tool by simulating human physiological characteristics and disease processes, which promotes the development of drug discovery, disease treatment and personalized medicine. With the continuous progress and innovation of the technology, it is believed that homology modeling technology will play an increasingly important role in the future and bring more breakthroughs for human health.

Keyword:

In the field of life sciences, every leap in technology leads to deeper research and medical advances. InnoModels Biotechnology (Beijing) Co., Ltd, with its innovative 3D organoid platform, is providing scientists with an unprecedented research tool, which greatly promotes drug research and development and the exploration of disease mechanisms
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
In the vast field of cancer research and drug development, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful support to scientists and doctors with its leading CDX (Cell line-derived xenograft tumor) model platform. The platform not only has diverse tumor cell lines, but also is equipped with a team of experienced experts and advanced experimental technologies, which are dedicated to promoting innovation in biomedical research and clinical treatment.
In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is leading the forefront of tumor and tumor immunotherapy research with its unique in vivo tumor experimental platform, which is like a bright star. The platform not only integrates the most advanced technologies and experimental methods, but also devotes itself to providing a new generation of experimental animal models close to the clinic
In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
Previous page
1
2
42

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司